Raymond James raised the firm’s price target on Intuitive Surgical (ISRG) to $603 from $592 and keeps an Outperform rating on the shares. Intuitive Surgical’s Q3 results were strong, with material upside across most metrics, including 23% revenue and 30% year over year EPS growth, the analyst tells investors in a research note. Management commentary’s was encouraging, especially around dV5 utilization trends, the firm adds.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $655 from $536 at Baird
- Intuitive Surgical price target raised to $610 from $595 at Piper Sandler
- Intuitive Surgical price target raised to $589 from $529 at BTIG
- Intuitive Surgical’s Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Intuitive Surgical’s Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating